The effect of α₂-adrenoceptor antagonists in isolated globally ischemic rat heartsSARGENT, C. A; DZWONCZYK, S; GROVER, G. J et al.European journal of pharmacology. 1994, Vol 261, Num 1-2, pp 25-32, issn 0014-2999Article

The endothelin-1 receptor antagonist BQ-123 reduces infarct size in a canine model of coronary occlusion and reperfusionGROVER, G. J; DZWONCZYK, S; PARHAM, C. S et al.Cardiovascular research. 1993, Vol 27, Num 9, pp 1613-1618, issn 0008-6363Article

Ruthenium red improves postischemic contractile function in isolated rat heartsGROVER, G. J; DZWONCZYK, S; SLEPH, P. G et al.Journal of cardiovascular pharmacology. 1990, Vol 16, Num 5, pp 783-789, issn 0160-2446, 7 p.Article

Effect of the potassium channel oepner EMD 56431 on globally ischemic rat heartsSARGENT, C. A; DZWONCZYK, S; GROVER, G. J et al.Pharmacology. 1992, Vol 45, Num 5, pp 260-268, issn 0031-7012Article

Role of myocardial ATP-sensitive potassium channels in mediating preconditioning in the dog heart and their possible interaction with adenosine A₁-receptorsGROVER, G. J; SLEPH, P. G; DZWONCZYK, S et al.Circulation (New York, N.Y.). 1992, Vol 86, Num 4, pp 1310-1316, issn 0009-7322Article

Comparative anti-ischemic effects of dihydropyridine calcium antagonists in isolated perfused rat hearts : relationship of cardiodepression and cardioprotectionGROVER, G. J; DZWONCZYK, S; SLEPH, P. G et al.Pharmacology. 1990, Vol 40, Num 3, pp 137-149, issn 0031-7012, 13 p.Article

Pharmacologic profile of cromakalim in the treatment of myocardial ischemia in isolated rat hearts and anesthetized dogsGROVER, G. J; SLEPH, P. G; DZWONCZYK, S et al.Journal of cardiovascular pharmacology. 1990, Vol 16, Num 6, pp 853-864, issn 0160-2446, 12 p.Article

Reduction of ischemic damage in isolated rat hearts by the potassium channel opener, RP 52891GROVER, G. J; DZWONCZYK, S; SLEPH, P. G et al.European journal of pharmacology. 1990, Vol 191, Num 1, pp 11-18, issn 0014-2999, 8 p.Article

The K_ATP blocker sodium 5-hydroxydecanoate does not abolish preconditioning in isolated rat heartsGROVER, G. J; MURRAY, H. N; BAIRD, A. J et al.European journal of pharmacology. 1995, Vol 277, Num 2-3, pp 271-274, issn 0014-2999Article

Cardioprotective effects of the potassium channel opener cromakalim : stereoselectivity and effects on myocardial adenine nucleotidesGROVER, G. J; NEWBURGER, J; SLEPH, P. G et al.The Journal of pharmacology and experimental therapeutics. 1991, Vol 257, Num 1, pp 156-162, issn 0022-3565, 7 p.Article

Preconditioning is not abolished by the delayed rectifier K⁺ blocker dofetilideGROVER, G. J; D'ALONZO, A. J; DZWONCZYK, S et al.American journal of physiology. Heart and circulatory physiology. 1996, Vol 40, Num 3, pp H1207-H1214, issn 0363-6135Article

The cardioprotective and electrophysiological effects of cromakalim are attenuated by meclofenamate through a cyclooxygenase-independent mechanismGROVER, G. J; D'ALONZO, A. J; SLEPH, P. G et al.The Journal of pharmacology and experimental therapeutics. 1994, Vol 269, Num 2, pp 536-540, issn 0022-3565Article

Glyburide-reversible cardioprotective effects of BMS-180448 : Functional and energetic considerationsGROVER, G. J; SLEPH, P. G; DZWONCZYK, S et al.Journal of cardiovascular pharmacology. 1997, Vol 29, Num 1, pp 28-38, issn 0160-2446Article

Protective effect of serotonin (5-HT₂) receptor antagonists in ischemic rat heartsGROVER, G. J; SARGENT, C. A; DZWONCZYK, S et al.Journal of cardiovascular pharmacology. 1993, Vol 22, Num 4, pp 664-672, issn 0160-2446Article

Specific block of the anti-ischemic actions of cromakalim by sodium 5-hydroxydecanoateMCCULLOUGH, J. R; NORMANDIN, D. E; CONDER, M. L et al.Circulation research. 1991, Vol 69, Num 4, pp 949-958, issn 0009-7330Article

Glyburide-reversible cardioprotective effects of calcium-independent phospholipase A₂ inhibition in ischemic rat heartsSARGENT, C. A; WILDE, M. W; DZWONCZYK, S et al.Cardiovascular research. 1996, Vol 31, Num 2, pp 270-277, issn 0008-6363Article

Endogenous catecholamines are not necessary for ischaemic preconditioning in the isolated perfused rat heartWESELCOUCH, E. O; BAIRD, A. J; SLEPH, P. G et al.Cardiovascular research. 1995, Vol 29, Num 1, pp 126-132, issn 0008-6363Article

In vitro effects of capsaicin : antiarrhythmic and antiischemic activityD'ALONZO, A. J; GROVER, G. J; DARBENZIO, R. B et al.European journal of pharmacology. 1995, Vol 272, Num 2-3, pp 269-278, issn 0014-2999Article

Pharmacologic profile of the dihydropyrimidine calcium channel blockers SQ 32,547 and SQ 32,946GROVER, G. J; DZWONCZYK, S; MCMULLEN, D. M et al.Journal of cardiovascular pharmacology. 1995, Vol 26, Num 2, pp 289-294, issn 0160-2446Article

Cardioselective anti-ischemic ATP-sensitive potassium channel openersATWAL, K. S; GROVER, G. J; MCCULLOUGH, J. R et al.Journal of medicinal chemistry (Print). 1993, Vol 36, Num 24, pp 3971-3974, issn 0022-2623Article

Effect of potassium channel blockade on the anti-ischemic actions of mechanistically diverse agentsSARGENT, C. A; SMITH, M. A; DZWONCZYK, S et al.The Journal of pharmacology and experimental therapeutics. 1991, Vol 259, Num 1, pp 97-103, issn 0022-3565Article

Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts : relationship between cardiac ACE inhibition and cardioprotectionGROVER, G. J; SLEPH, P. G; DZWONCZYK, S et al.The Journal of pharmacology and experimental therapeutics. 1991, Vol 257, Num 3, pp 919-929, issn 0022-3565Article